logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Jonathan W. Goldman

james cancer hospital & solove research institute

67H-index
793Paper Count
3.4WCitation Count
Published Papers 117
Publication Date
logo
Small Cell Lung Cancer, Version 2.2026 Featured Updates to the NCCN Guidelines
errJournal of the National Comprehensive Cancer Network
IF16.4
err2026-01-01
err0
PREAI
errGanti, Apar Kishor P.; Loo, Billy W.; Badiyan, Shahed; Bassetti, Michael; Bestvina, Christine; Chiang, Anne; Choudhury, Noura; D'Avella, Christopher A.; Daly, Megan; Dowlati, Afshin; Edelman, Martin; Florsheim, Charles; Gold, Kathryn A.; Goldman, Jonathan W.; Grecula, John C.; Hann, Christine; Khalil, Maya; Lee, Robert; Malhotra, Jyoti; Merritt, Robert E.; Mohindra, Nisha; Molina, Julian R.; Moran, Cesar; Mulvey, Claire; Osmundson, Evan C.; Patel, Shiven; Patil, Tejas; Pokharel, Saraswati; Puri, Sonam; Qin, Angel; Sands, Jacob; Shields, Misty; Tailor, Tina D.; Waqar, Saiama N.; Cassara, Carly J.; Ramakrishnan, Swathi
errShare
errSave
Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer
errCHEST
IF8.6
err2025-11-12
err0
PREAI
errSara Sakowitz; Haley I. Tupper; Lawrence N. Benjamin; Scott Oh; Tao He; Reza Ronaghi; Colleen L. Channick; Brian J. Rosenberg; Ramin Salehi-rad; Malcolm I. Smith; Joanne M. Bando; Timothy J. Young; Igor Barjaktarvic; Maria A. Velez Velez; Arjan Gower; Amy L. Cummings; Jonathan Goldman; Aaron E. Lisberg; Edward B. Garon; Jane Yanagawa
errShare
errSave
Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report
errJournal of Thoracic Oncology
IF20.8
err2025-10-21
err0
PREAI
errXiuning Le; Christina Baik; Byoung Chul Cho; Jonathan W. Riess; Zofia Piotrowska; Adrianus Johannes de Langen; Sarah B. Goldberg; Jonathan W. Goldman; Noemi Reguart; Yoshimasa Shiraishi; Helen Ambrose; Paula G. Fraenkel; Brayan Merchan Ruiz; Paul E. Smith; Kwan Ho Tang; Helena A. Yu
errShare
errSave
Durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: outcomes in age, sex, and platinum subgroups from the phase 3 CASPIAN study
errClinical Lung Cancer
IF3.3
err2025-08-05
err0
errOAAI
errNiels Reinmuth; Jonathan W. Goldman; Yuanbin Chen; Katsuyuki Hotta; Dmytro Trukhin; Galina Statsenko; Maximilian Hochmair; Mustafa Özgüroğlu; Jun Ho Ji; Marina Chiara Garassino; Artem Poltoratskiy; Francesco Verderame; Libor Havel; Igor Bondarenko; György Losonczy; Nikolay Conev; Shannon Kummer; Helen Mann; Priti Chugh; Tapashi Dalvi; Luis Paz-Ares
errShare
errSave
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report
errJournal of Thoracic Oncology
IF20.8
err2025-06-04
err0
errOAAI
errGregory J. Riely; Myung-Ju Ahn; Jeffrey M. Clarke; Ibiayi Dagogo-Jack; Raymond Esper; Enriqueta Felip; Francesco Gelsomino; Jonathan W. Goldman; Maen Hussein; Melissa Johnson; Kristen A. Marrone; Daniel Morgensztern; Ernest Nadal; Marcelo V. Negrao; Michael Offin; Mariano Provencio; Suresh S. Ramalingam; Logan Roof; Rachel E. Sanborn; Egbert F. Smit; Anne Tsao; Tiziana Usari; Ann Alcasid; Keith Wilner; Svitlana Tonkovyd; Xiaosong Zhang; Bruce E. Johnson
errShare
errSave
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study
errJournal of Thoracic Oncology
IF20.8
err2025-05-16
err0
PREAI
errMatthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
errShare
errSave
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study
errFUTURE ONCOLOGY
IF2.6
err2025-05-07
err0
errOAAI
errOzguroglu, Mustafa; Goldman, Jonathan W.; Chen, Yuanbin; Garassino, Marina Chiara; Medic, Nenad; Mann, Helen; Chugh, Priti; Dalvi, Tapashi; Paz-Ares, Luis
errShare
errSave
Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients
errClinical Lung Cancer
IF3.3
err2025-03-31
err0
errOAAI
errMichael S. Oh; Edward B. Garon; Aaron E. Lisberg; Amy L. Cummings; Alex Barrett; Arya Ashok; Elizabeth Mauer; Binyam Yilma; Jonathan W. Goldman
errShare
errSave
Water Disinfection Systems for Pools and Spas: Advantages, Disadvantages, and Consumer Views in the US
errACS ES&T WATER
IF4.3
err2025-01-09
err0
errOAAI
errJarin, Mourin; Ly, Jackie; Goldman, Jonathan; Xie, Xing
errShare
errSave
Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib
errANNALS OF ONCOLOGY
IF65.4
err2025-01-01
err2
PREAI
errHorinouchi, H.; Cho, B. C.; Camidge, D. R.; Goto, K.; Tomasini, P.; Li, Y.; Vasilopoulos, A.; Brunsdon, P.; Hoffman, D.; Shi, W.; Bolotin, E.; Blot, V.; Goldman, J.
errShare
errSave
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
errMOLECULAR CANCER
IF33.9
err2024-05-30
err4
errOAAI
errXie, Mingchao; Vuko, Miljenka; Rodriguez-Canales, Jaime; Zimmermann, Johannes; Schick, Markus; O'Brien, Cathy; Paz-Ares, Luis; Goldman, Jonathan W.; Garassino, Marina Chiara; Gay, Carl M.; Heymach, John V.; Jiang, Haiyi; Barrett, J. Carl; Stewart, Ross A.; Lai, Zhongwu; Byers, Lauren A.; Rudin, Charles M.; Shrestha, Yashaswi
errShare
errSave
Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells in combination with pembrolizumab for advanced NSCLC: Feasibility of repeated IT injections
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errLiu, Bin; Lisberg, Aaron; Salehi-Rad, Ramin; Oh, Michael; Lee, Jay M.; Tran, Linh M.; Krysan, Kostyantyn; Lim, Raymond J.; Dumitras, Camelia; Jing, Zhe; Abtin, Fereidoun; Suh, Robert D.; Genshaft, Scott J.; Oh, Scott S.; Fishbein, Gregory A.; Kaul, Anita; Kahlon, Kanwarpal S.; Ashouri, Shahryar A.; Goldman, Jonathan W.; Elashoff, David A.; Garon, Edward; Dubinett, Steven M.
errShare
errSave
Amivantamab in wild-type advanced non-small cell lung cancer after disease progression on checkpoint inhibition and chemotherapy: Results from the phase 1b CHRYSALIS study
errCANCER RESEARCH
IF16.6
err2024-04-05
err0
PREAI
errCho, Byoung Chul; Goldman, Jonathan; Leighl, Natasha; De Braud, Filippo; Lee, Ki Hyeong; Ghiringhelli, Francois; Garrido, Pilar; Peguero, Julio; Besse, Benjamin; Cassier, Philippe; Girard, Nicolas; de Miguel, Maria; Alvarez, Rosa; Greystroke, Alastair; Ohe, Yuichiro; Hsia, Te-Chun; Curtin, Joshua C.; Chowdhury, Sanjib; Lyu, Xuesong; Gao, Grace; Qu, Siyang; Lorenzini, Patricia; Kapoor, Aastha; Kim, Priya; Baig, Mahadi; Thayu, Meena; Knoblauch, Roland E.; Hiret, Sandrine; Tomasini, Pascale
errShare
errSave
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
errNATURE MEDICINE
IF50
err2024-03-27
err16
PREAI
errRappaport, Amy R.; Kyi, Chrisann; Lane, Monica; Hart, Meghan G.; Johnson, Melissa L.; Henick, Brian S.; Liao, Chih-Yi; Mahipal, Amit; Shergill, Ardaman; Spira, Alexander I.; Goldman, Jonathan W.; Scallan, Ciaran D.; Schenk, Desiree; Palmer, Christine D.; Davis, Matthew J.; Kounlavouth, Sonia; Kemp, Lindsey; Yang, Aaron; Li, Yaojun John; Likes, Molly; Shen, Annie; Boucher, Gregory R.; Egorova, Milana; Veres, Robert L.; Espinosa, J. Aaron; Jaroslavsky, Jason R.; Tardif, Lauren D. Kraemer; Acrebuche, Lindsey; Puccia, Christopher; Sousa, Leiliane; Zhou, Rita; Bae, Kyounghwa; Hecht, J. Randolph; Carbone, David P.; Johnson, Benny; Allen, Andrew; Ferguson, Andrew R.; Jooss, Karin
errShare
errSave
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
errTARGETED ONCOLOGY
IF4
err2024-03-11
err0
errOAAI
errTsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Bonanno, Laura; Domine, Manuel; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long
errShare
errSave
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
errFUTURE ONCOLOGY
IF2.6
err2024-02-15
err0
errOAAI
errRiely, Gregory J.; Smit, Egbert F.; Ahn, Myung-Ju; Felip, Enriqueta; Ramalingam, Suresh S.; Tsao, Anne; Johnson, Melissa; Gelsomino, Francesco; Esper, Raymond; Nadal, Ernest; Offin, Michael; Provencio, Mariano; Clarke, Jeffrey; Hussein, Maen; Otterson, Gregory A.; Dagogo-Jack, Ibiayi; Goldman, Jonathan W.; Morgensztern, Daniel; Alcasid, Ann; Usari, Tiziana; Wissel, Paul; Wilner, Keith; Pathan, Nuzhat; Tonkovyd, Svitlana; Johnson, Bruce E.
errShare
errSave
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-11-30
err91
PREAI
errZhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Liu, Baogang; Paz-Ares, Luis; Cheng, Susanna; Kitazono, Satoru; Thiagarajan, Muthukkumaran; Goldman, Jonathan W.; Sabari, Joshua K.; Sanborn, Rachel E.; Mansfield, Aaron S.; Hung, Jen-Yu; Boyer, Michael; Popat, Sanjay; Mourao Dias, Josiane; Felip, Enriqueta; Majem, Margarita; Gumus, Mahmut; Kim, Sang-we; Ono, Akira; Xie, John; Bhattacharya, Archan; Agrawal, Trishala; Shreeve, S. Martin; Knoblauch, Roland E.; Park, Keunchil; Girard, Nicolas; PAPILLON Investigators
errShare
errSave
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-11-23
err140
PREAI
errPlanchard, D.; Janne, P. A.; Cheng, Y.; Yang, J. C. -H.; Yanagitani, N.; Kim, S-W; Sugawara, S.; Yu, Y.; Fan, Y.; Geater, S. L.; Laktionov, K.; Lee, C. K.; Valdiviezo, N.; Ahmed, S.; Maurel, J-M; Andrasina, I; Goldman, J.; Ghiorghiu, D.; Rukazenkov, Y.; Todd, A.; Kobayashi, K.
errShare
errSave
Phase 1b efficacy of telisotuzumab vedotin and osimertinib in Asian vs non-Asian patients with advanced NSCLC
errANNALS OF ONCOLOGY
IF65.4
err2023-11-01
err0
errOAAI
errHorinouchi, Hidehito; Goldman, Jonathan; Cho, Byoung Chul; Tomasini, Pascale; Dunbar, Martin; Hoffman, David; Parikh, Apurvasena; Blot, Vincent; Camidge, D. Ross
errShare
errSave
Telisotuzumab vedotin monotherapy in Asian patients with c-Meteoverexpressing advanced non-small cell lung cancer
errANNALS OF ONCOLOGY
IF65.4
err2023-11-01
err0
errOAAI
errHorinouchi, Hidehito; Camidge, D. Ross; Bar, Jair; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Bradbury, Penelope; Daaboul, Nathalie; Tomasini, Pascale; Ciuleanu, Tudor; Planchard, David; Moskovitz, Mor; Girard, Nicolas; Dunbar, Martin; Bolotin, Ellen; Looman, Jim; Ratajczak, Christine; Lu, Shun
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
John C. Morris
H-index: 212 · Papers: 2.4K
J
John D. Minna
H-index: 174 · Papers: 2.3K
K
Keith T. Flaherty
H-index: 146 · Papers: 1.7K
R
Richard L. Huganir
H-index: 145 · Papers: 490
P
Patrick Y. Wen
H-index: 145 · Papers: 1.9K
View more